| Autor: |
Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Mufti GJ; Department of Haemato-Oncology, King's College London, London, United Kingdom., Fenaux P; Service d'Hématologie Séniors, Hôpital Saint Louis, Université Paris 7, Paris, France., Buckstein R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Santini V; MDS Unit, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Díez-Campelo M; Hematology Department, Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain., Finelli C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli' Bologna, Bologna, Italy., Ilhan O; Department of Hematology, Ankara University School of Medicine, Ankara, Turkey., Sekeres MA; Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, FL., Zeidan AM; Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT., Ito R; Bristol Myers Squibb, Princeton, NJ., Zhang J; Bristol Myers Squibb, Princeton, NJ., Rampersad A; Bristol Myers Squibb, Princeton, NJ., Sinsimer D; Bristol Myers Squibb, Princeton, NJ., Backstrom JT; Acceleron Pharma, Cambridge, MA., Platzbecker U; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany; and., Komrokji RS; Moffitt Cancer Center, Tampa, FL. |
